Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis-Reference-Cited by-同舟云学术

Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis

Published:2018-08 Issue:8 Volume:5 Page:e359-e367
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Federico Massimo,Caballero Barrigón María Dolores,Marcheselli Luigi,Tarantino Vittoria,Manni Martina,Sarkozy Clementine,Alonso-Álvarez Sara,Wondergem Marielle,Cartron Guillaume,Lopez-Guillermo Armando,Issa Djamila,Morschhauser Franck,Alcoceba Miguel,Kimby Eva,Rusconi Chiara,Chamuleau Martine,Holte Harald,Lockmer Sandra,Montoto Silvia,Gomes da Silva Maria,Aurer Igor,Zucca Emanuele,Paszkiewicz-Kozik Ewa,Minoia Carla,Skrypets Tetiana,Blaker Yngvild Nuvin,Salles Gilles,Coiffier Bertrand

Publisher

Elsevier BV

Subject

Hematology

Reference25 articles.

1. WHO classification of tumors of haematopoietic and lymphoid tissues;Swerdlow,2008

2. Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy;Luminari;Hematol Oncol,2007

3. Transformed follicular non-Hodgkin lymphoma;Casulo;Blood,2015

4. Incidence, risk factors and outcome of histological transformation in follicular lymphoma;Conconi;Br J Haematol,2012

5. Histologic progression in non-Hodgkin's lymphoma;Hubbard;Blood,1982

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and future therapies for follicular lymphoma;Experimental Hematology & Oncology;2024-08-22

2. Reappraisal of autologous stem cell transplantation for transformed indolent lymphoma in the bendamustine era;Bone Marrow Transplantation;2024-08-20

3. Risk of transformation by frontline management in follicular and marginal zone lymphomas: a US population–based analysis;Blood Advances;2024-08-16

4. Diagnosis, management and follow‐up of follicular lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance;Internal Medicine Journal;2024-08

5. Generation and External Validation of a Histologic Transformation Risk Model for Patients with Follicular Lymphoma;Modern Pathology;2024-07